Transposon

Transposon Therapeutics is a pharmaceutical company based in Westport, Connecticut, focused on developing innovative therapeutics for debilitating and life-threatening diseases, particularly neurodegenerative disorders and diseases associated with aging. The company is in the clinical stage and is engaged in the research and development of nucleoside inhibitors targeting LINE-1 reverse transcriptase and other mediators linked to LINE-1 pathology. By addressing these critical areas, Transposon Therapeutics aims to provide effective treatment options for patients suffering from conditions that significantly impact their quality of life.